A Huge Automobile Dealer Is Raking In Cash. This is Why Autonation Inventory Is Soaring

  • AutoNation Inc (NYSE: AN) reported fourth-quarter FY22 profits development of 2% yr-on-calendar year to $6.69 billion, beating the consensus of $6.52 billion.

  • Larger common marketing price ranges of automobiles, greater new auto device gross sales, and continued growth in Following-Product sales, a lot more than offset lower applied car or truck unit income.

  • New vehicle retail device profits rose 4%, and applied vehicle retail unit profits declined 9%.

  • Phase revenue from Domestic fell 25% Y/Y, Import dropped 5%, and Premium Luxury was flat.

  • Gross financial gain declined 3% Y/Y to $1.28 billion, and the gross earnings margin contracted 20 foundation factors Y/Y to 19.1%. After-Profits gross income improved 12% to $479 million.

  • Selling, typical and administrative (SG&A) costs increased by 1.5%.

  • Working margin for the quarter was 6.3%, and the functioning income was $424.9 million, a 20% Y/Y decrease.

  • Altered EPS of $6.37 conquer the consensus of $5.83.

  • Hard cash and equivalents totaled $72.6 million as of Dec. 31, 2022. The company reported its comprehensive-year 2022 hard cash flows from functions ended up a record $1.7 billion.

  • In 2022, the corporation diminished shares outstanding by 25% as it repurchased 15.6 million shares, together with 4.6 million through the fourth quarter.

  • As of Feb. 15, 2023, AutoNation had roughly 47 million shares fantastic, down from 83 million at the conclusion of 2020.

  • Cost Action: AN shares are trading greater by 8.01% at $152.43 on the final check out Friday.

You should not miss authentic-time alerts on your shares – join Benzinga Pro for totally free! Check out the resource that will support you invest smarter, more quickly, and far better.

This write-up A Large Automobile Seller Is Raking In Money. Here is Why Autonation Inventory Is Soaring originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not offer investment decision guidance. All legal rights reserved.

Leave a Reply